However, since APOE ε4/ε4 was more prevalent in biomarker-diagnosed AD, it suggested that APOE ε4/ε4 was closely related to the development of AD but had no further influence on the biomarkers after AD development. The gene discussed is APOE; the disease is Alzheimer disease.